Hayden Jeffreys

Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.

Part of Novacyt SAS, Yourgene Health UK Ltd. is a company that engages in developing prenatal diagnostic products for molecular testing laboratories. Yourgene Health UK Ltd. is based in Manchester, UK. Yourgene Health was acquired by ViaLogy Plc on July 04, 2014 for $64.97 million. The British company was founded in 2013.

ERBA Diagnostics Mannheim GmbH manufactures and distributes diagnostic products. It offers solutions in biochemistry, hematology, immunology, critical care, coagulation, urine analysis, electrophoresis, diabetes, microbiology, and molecular diagnosis. The firm also develops, manufactures, and distributes diagnostic reagents, test kits, and instrumentation for autoimmune and infectious diseases and manufactures in-vitro diagnostic kits for use in clinical and hospital laboratories. The company was founded by Suresh Vazirani in 1979 and is headquartered in Mannheim, Germany.

Part of Novacyt SAS, Yourgene Health UK Ltd. is a company that engages in developing prenatal diagnostic products for molecular testing laboratories. Yourgene Health UK Ltd. is based in Manchester, UK. Yourgene Health was acquired by ViaLogy Plc on July 04, 2014 for $64.97 million. The British company was founded in 2013.

Part of Novacyt SAS, Yourgene Health UK Ltd. is a company that engages in developing prenatal diagnostic products for molecular testing laboratories. Yourgene Health UK Ltd. is based in Manchester, UK. Yourgene Health was acquired by ViaLogy Plc on July 04, 2014 for $64.97 million. The British company was founded in 2013.